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ABBREVIATION 
APN      :  Acute Pyelonephritis 
CBC      :  Complete Blood Count 
CRP      :  C-Reactive Protein 
CT        :   Computed Tomography 
DAMP :  Damage Associated Molecular Patterns 
DM      :  Diabetes Mellitus 
ESBL  :  Extended spectrum β lactamase 
IDSA  :  Infectious Diseases Society of America 
LTCF : Long Term Care Facilities 
MRSA : Methicillin Resistant Staphylococcus Aureus 
PAMP :Pathogen Associated Molecular Patterns 
SGLT : Sodium-glucose Transporter 
SMX   : Sulfamethoxazole 
TB      : Tuberculosis 
TMP   : Trimethoprim 
USG    : Ultrasonogram 
 
UTI     : Urinary Tract Infection 
VUR    : Vesico-Ureteric Reflux 
WBC   : White Blood Cells 
XGP    : Xanthogranulomatous Pyelonephritis 
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INTRODUCTION 
  Urinary tract infection may involve only the lower 
urinary tract or both the upper and lower tracts. The term cystitis has been 
used to describe the syndrome involving dysuria, frequency, urgency, and 
occasionally suprapubic tenderness. However, these symptoms may be 
related to lower tract inflammation without bacterial infection and can be 
caused by urethritis (e.g., gonorrhea or chlamydial urethritis). 
Furthermore, the presence of symptoms of lower tract infection without 
upper tract symptoms by no means excludes upper tract infection, which 
is also often present. Acute pyelonephritis describes the clinical syndrome 
characterized by flank pain, tenderness, or both, and fever, often 
associated with dysuria, urgency, and frequency. However, these 
symptoms can occur in the absence of infection (e.g., in renal infarction 
or renal calculus).A more rigorous definition of acute pyelonephritis is 
the previously described syndrome accompanied by significant 
bacteriuria and acute infection in the kidney. Uncomplicated urinary tract 
infection refers to infection in a structurally and neurologically normal 
urinary tract. Complicated urinary tract infection refers to infection in a 
urinary tract with functional or structural abnormalities, including 
indwelling catheters and calculi[1]. In general, infection in men, pregnant 
women, children, and patients who are hospitalized or in health care–
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associated settings may be considered complicated. In the patient with 
complicated infection, infecting microorganisms are more likely to be 
resistant to antimicrobial agents.  
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      AIMS AND OBJECTIVES 
 
To explore a diagnostic method to differentiate for upper and lower 
urinary tract Infections. 
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REVIEW OF LITERATURE 
Urinary tract infection   
In adults UTI can be classified into 5 groups[2] 
• Uncomplicated cystitis in women 
• Recurrent cystitis in women 
• Acute uncomplicated pyelonephritis in women  
• Complicated UTI  
• Asymptomatic bacteriuria  
Complicated UTI  
 It is defined as urinary tract infection that increases risk for 
serious complications or treatment failure. 
Complicated UTIs may require different pre treatment and post 
treatment  evaluation and duration of anti-microbial treatment than for 
UN complicated UTI.  Occasionally complicated UTIs are diagnosed 
after a poor response to treatment. 
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Factors modulating risk of acute uncomplicated urinary tract 
infections in women: 
 
picture 1:Factors complicating Uncomplicated UTI in women 
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Epidemiology 
The incidence of acute cystitis in sexually active women is about 
0.5 per 1 person year[3]. The incidence of acute pyelonephritis in young 
women is about 3/1000 person –years[4]. The incidence of symptomatic 
urinary tract infection in  adult men less than 50 years is much lower than 
seen in women ranging from 5 to 8 /10000 men annually.  
Nosocomial urinary tract infections are a common cause of 
complicated UTI which occurs in 5% of admission in tertiary care 
hospitals. In hospitalized patients , catheter associated bacteriuria is the  
most common source of gram-negative bacteremia[5].  
Asymptomatic bacteriuria is defined as presence of 105  or more 
colony forming units per ml of the organism in 2 separate consecutive 
clean voided urine specimen in the absence of symptom related to the 
urinary tract[6]. It is found in about 5% of adult young women[7] and very 
rarely in men less than 50 years. 
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Pathogenesis 
Uncomplicated  infection 
Most of uncomplicated UTIs in healthy women result when 
organisms such as E.coli present in rectum enter the urinary bladder after 
an interim phase of distal urethral colonization. Staphylococcus aureus 
seed the urinary tract by hematogeneous spread.   
The protective factors from urinary tract infection include  
− Host‘s immune response  
− Maintanence of normal vaginal flora  
− Removal of urinary bladder bacteriuria by micturition[8] . 
 P-fimbriated Strains of Escherichia coli are associated with 
acute uncomplicated pyelonephritis. Their adherence properties stimulate 
epithelial and other cells to produce inflammatory factors that stimulate 
the inflammatory response[9] . 
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Figure 2. 
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The determinants of virulence include  
o Adherence factor (type 1, S, and Dr fimbriae) 
o Toxins(hemolysin) 
o Immune evasion 
o Iron acquisition(aerobactin) 
o Flagella 
o serum resistance [10] 
The factors responsible for decreased prevalence of UTI in men include; 
i. Greater distance between the anus and the urethral meatus 
ii. Drier environment surrounding male urethra 
iii. Greater length of male urethra 
Risk factors for urinary tractinfection in young healthy men include; 
¾ Intercourse with an infected female partner 
¾ Anal intercourse 
¾ Lack of circumcision 
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Complicated infection ; 
The predisposing factors that lead to complicated UTI include; 
o Obstruction or stasis of urine flow 
o Facilatiting entry of organisms into urinary tract by bypassing  
host defence mechanisms 
o Providing a nidus for infection not readily treatable with 
antimicrobials 
o Compromising the host immune system 
Complicated UTIs occur in settings of impaired host defence such as  
¾ Indwelling catheter use 
¾ VUR  
¾ Obstruction 
¾ Neutropenia 
¾ Immune deficiencies 
Diabetes mellitus is associated with syndromes of complicated UTI 
including 
1. Renal and perirenal abscess 
2. Emphysematous pyelonephritis and cystitis 
3. Papillary necrosis 
4. Xanthogranulomatous pyelonephritis 
11 
 
The virulence of the pathogens are less important in the 
pathogenesis of complicated urinary tract infections compared with 
uncomplicated urinary tract infections.But,multidrug resistance is 
more likely with complicated urinary tract infections. 
 
 
Figure 3. 
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ETIOLOGICAL AGENTS; 
BACTERIAL ETIOLOGY OF URINARY TRACT INFECTIONS 
Picture 4:Bacterial organisms causing UTI 
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Uncomplicated upper and lower urinary tract infections are most 
often caused by Escherichia coli in 70% to 95% and staphylococcus 
saphrophyticus present in 5% to 20%. The common contaminants in 
healthy non-pregnant women include lactobacilli, enterococci, coagulase 
negative staphylococcus and group B streptococci. 
 E.coli is the most common bacteria in complicated UTIs. 
Other organisms include citrobacter spp.,Enterobacter spp., enterococci, 
pseudomonas aeruginosa,staph.aureus. UTIs caused by fungi ,especially 
candida spp., is increasing. Polymicrobial and multidrug resistant 
infections are more likely in patients with chronic conditions such as 
neurogenic bladder and spinal cord injury. 
 
  
Figure 5. Factors that promote the recurrence of UTI 
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CLINICAL SYNDROMES 
Figure 6. 
Acute uncomplicated cystitis in young women;  
They present with symptoms such as acute onset of 
dysuria,frequency,urgency or suprapubic pain. In a sexually active young 
women acute cystitis usually presents with acute dysuria. Neisseria 
gonorrhoeae,chlamydia trachomatis,or herpes simplex virus infections 
presents with acute urethritis.  Candida spp. Or Trichomonas vaginalis 
presents with vaginitis.Definitive diagnosis of urinary tract infection 
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requires the presence of significant bacteriuria ,which is 105  or more 
uropathogens per ml of midstream voided urine. The IDSA ( Infectious 
Diseases Society of America) consensus definition of cystitis is 103 cfu 
per milliliter or more uropathogens[11].Generally,urine cultures are not 
required  in women with uncomplicated cystitis because patient’s history 
is highly reliable in establishing the diagnosis[12]. 
 Increasing resistance is often encountered for E.coli in 
uncomplicated UTIs to sulfonamides, amoxicillin, cotrimoxazole. 
Nitrofurantoin resistance to E.coli is less than 5%,although it is inactive 
against proteus spp. And some klebsiella spp and Enterobacter.In 
uncomplicated cystitis, E.coli strains are susceptible to fluoroquinolones 
although resistance is increasing in many parts of the world[13,14]. 
Infections caused by  ESBL (extended spectrum β-lactamase) producing 
strains are increasing in number in addition,even in the setting of 
uncomplicated urinary tract infection. 
Recurrent Acute Uncomplicated Cystitis in Women 
 Much recurrent cystitis in healthy women is caused by 
persistence of the initially infecting strain in the fecal flora[15]. 
Experimental studies in mice also suggest that some same-strain recurrent 
UTIs may be caused by a latent reservoir of uropathogens in the bladder 
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epithelium that persist after the initial UTI[16], and indirect evidence 
indicates that this may occur in humans[17]. If the recurrence is within 1 or 
2 weeks of treatment, an antimicrobial-resistant uropathogen should be 
considered, and a urine culture should be performed followed by 
treatment with an alternative regimen. 
Acute Uncomplicated Pyelonephritis in Women 
Acute pyelonephritis is suggested by fever (temperature ≥38° C), 
chills, flank pain, nausea and vomiting, and costovertebral angle 
tenderness. Cystitis symptoms are variably present. Symptoms may vary 
from a mild illness to a sepsis syndrome with or without shock and renal 
failure. Pyuria is almost always present, but leukocyte casts, specific for 
UTI, are infrequently seen. Gram stain of the urine sediment may aid in 
differentiating gram-positive and gram-negative infections, which can 
influence empiric therapy. A urine culture, which should be performed in 
all women with acute pyelonephritis, will have 104 cfu/ml or more of 
uropathogens in up to 95% of patients[11]. On pathologic examination, the 
kidney shows a focal inflammatory reaction with neutrophil and 
monocyte infiltrates, tubular damage, and interstitial edema . Although 
imaging studies are generally not performed, the infected kidney is often 
enlarged, and contrast enhanced computed tomography (CT) shows 
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decreased opacification of the affected parenchyma, typically in patchy, 
wedge-shaped, or linear patterns. 
Picture 6:Histopathology of Acute Pyelonephritis 
Complicated Infections 
Patients with complicated UTI may present with classic signs of 
cystitis and pyelonephritis but also may have vague or nonspecific 
symptoms, such as fatigue, irritability, nausea, headache, and abdominal 
or back pain. Acute cystitis in healthy individuals other than young 
women is more likely to involve occult renal or prostatic infection and 
may respond poorly to short-course therapy. Noninvasive tools to localize 
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infections to the kidney or prostate are lacking, so clinical estimation of 
risk in a given patient is imprecise. Some patients, such as those who are 
diabetic or pregnant, warrant special attention because of the serious 
complications that can occur if treatment is inadequate. Urethritis must be 
excluded in dysuric sexually active men by a urethral Gram stain or a 
first-voided urine specimen wet-mount evaluation for urethral 
leukocytosis. 
Complicated UTI, as with uncomplicated infection, is generally 
associated with pyuria and bacteriuria, although these may be absent if 
the infection does not communicate with the collecting system. 
Urine culture should always be performed in patients with 
suspected complicated UTI. The IDSA consensus definition of 
complicated UTI is 105 cfu/ml or more in the urine of women and 104 
cfu/ml or more in men, but lower counts in symptomatic persons, as 
demonstrated in patients with uncomplicated UTI, may well represent 
significant bacteriuria. This is especially true when the specimen is 
collected from a urinary catheter. Thus it is reasonable to use a colony 
count threshold of 103 cfu/ml of uropathogens to diagnose complicated 
UTI. 
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Catheter-Associated Infections;  
Approximately 15% to 25% of patients in general hospitals have a 
urethral catheter inserted at some time during their stay, and 
approximately 5% to 10% of long-term care facility residents are 
managed with urethral catheterization, in some cases for years. The 
incidence of bacteriuria associated with indwelling catheters is 3% to 
10% per day of catheterization, and the duration of catheterization is the 
most important risk factor for the development of catheter-associated 
bacteriuria. 
 Catheter-associated bacteriuria is the most common source 
of gram negative bacteremia in hospitalized patients. Complications of 
long-term catheterization (≥30 days) include almost universal bacteriuria, 
often with multiple antibiotic-resistant flora, and (in addition to cystitis, 
pyelonephritis, and bacteremia, as seen with short-term catheterization) 
frequent febrile episodes, catheter obstruction, stone formation associated 
with urease-producing uropathogens, and local genitourinary infections. 
Other rare complications include fistula formation and bladder cancer. An 
increase in mortality risk has been reported with catheter associated 
bacteriuria, but it is difficult to distinguish the role of the catheter because 
most deaths occur in patients who have severe underlying disease. 
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Spinal Cord Injury; 
 Spinal cord injury alters the dynamics of voiding and often 
requires the use of bladder drainage with catheters. The diagnosis of UTI 
in patients with spinal cord injuries is often problematic and is based on 
the combination of symptoms and signs (which are often nonspecific), 
pyuria, and significant bacteriuria.  
Prostatitis;  
Prostatitis occurs in up to 25% of men during their lifetime, but it 
is caused by acute or chronic bacterial infection in a minority[18]. 
 The most common organisms causing bacterial prostatitis are 
gram-negative bacilli, including E. coli, Proteus spp., Klebsiella spp., 
P.aeruginosa, and, less frequently, enterococci and S. aureus. The 
pathogenesis of prostatitis is believed to be related to reflux of infected 
urine from the urethra into the prostatic ducts. Prostatic calculi, 
commonly found in adult men, may provide a nidus for bacteria and 
protection from antibacterial agents.Acute bacterial prostatitis is rare. 
Patients present with dysuria, frequency,urgency, obstructive voiding 
symptoms, fever, chills, and myalgias.The prostate is tender and swollen. 
Prostatic massage, as a diagnostic test, is contraindicated in men in whom 
the diagnosis of acute prostatitis is being considered because of the risk 
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for precipitating bacteremia. The patient will usually have pyuria and a 
positive urine culture.re usually present in quantities of 105 cfu/ml or 
more. 
  Chronic bacterial prostatitis is characterized by recurrent 
UTIs with the same uropathogen with intervening asymptomatic periods. 
The prostate typically is normal to palpation during asymptomatic 
periods.Chronic bacterial prostatitis is characterized microscopically by 
the presence of 10 or more leukocytes per high-power field in expressed 
prostatic secretions or postmassage voided urine in the absence of 
significant pyuria in first-voided and midstream urine specimens, as well 
as a uropathogen colony count at least 10-fold higher in the expressed 
prostatic secretions or postmassage voided urine compared with the first-
voided midstream urine. In addition, macrophage-laden fat droplets (oval 
fat bodies) are usually prominent in the prostatic secretions. 
Renal Abscess; 
Renal cortical and cortico medullary abscesses and perirenal 
abscesses occur in 1 to 10 per 10,000 hospital admissions[19] .Patients 
usually present with fever, chills, back or abdominal pain, and 
costovertebral angle tenderness, but they may have no urinary symptoms 
or findings if the abscess does not communicate with the collecting 
system, as often occurs with a cortical abscess. Bacteremia may be 
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primary (cortical abscess) or secondary (corticomedullary or perirenal). 
The clinical presentation may be insidious and nonspecific, especially 
with perirenal abscess, and the diagnosis may not be made until 
admission to a hospital or at autopsy. CT is recommended to establish the 
diagnosis and location of a renal or perirenal abscess. A renal cortical 
abscess (renal carbuncle) is usually caused by S.aureus, which reaches 
the kidney by hematogenous spread. A renal corticomedullary abscess, in 
contrast, usually results from ascending UTI in association with an 
underlying urinary tract abnormality, such as obstructive uropathy or 
VUR, and is usually caused by common uropathogenic species such as E. 
coli and other gram-negative bacilli. Such abscesses may extend deep 
into the renal parenchyma, perforate the renal capsule, and form a 
perirenal abscess. Perirenal abscesses usually occur in the setting of 
obstruction or other complicating factors  and result from ruptured 
intrarenal abscesses, hematogenous spread, or spread from a contiguous 
infection. Causative uropathogens are those usually found in complicated 
UTIs, including S. aureus and enterococci; polymicrobial infections are 
common. Anaerobes or Mycobacterium tuberculosis may be causative. 
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Papillary Necrosis 
 More than half of patients who develop papillary necrosis have 
diabetes, almost always in conjunction with a UTI, but the condition also 
complicates sickle cell disease, analgesic abuse, and obstruction. Renal 
papillae are vulnerable to ischemia because of the sluggish blood flow in 
the vasa recta, and relatively modest ischemic insults may cause papillary 
necrosis. The clinical features are those typical of pyelonephritis. In 
addition, passage of sloughed papillae into the ureter may cause renal 
colic, renal impairment or failure, or obstruction with severe urosepsis. 
Papillary necrosis in the setting of pyelonephritis is associated with 
pyuria and a positive urine culture. Causative uropathogens are those 
typical of complicated UTI. CT is the preferred diagnostic procedure. 
Radiologic findings include an irregular papillary tip; dilated calyceal 
fornix; extension of contrast material into the parenchyma; and a 
separated crescent-shaped papilla surrounded by contrast, called the ring 
sign 
24 
 
Figure 7. 
Emphysematous Pyelonephritis 
Emphysematous pyelonephritis is a fulminant, necrotizing, life-
threatening variant of acute pyelonephritis caused by gas-forming 
organisms, including E. coli, Klebsiella pneumoniae, P. aeruginosa, and 
Proteus mirabilis[20]. Up to 90% of cases occur indiabetic patients, and 
obstruction may be present. Symptoms are suggestive of pyelonephritis, 
and there may be a flank mass. Dehydration and ketoacidosis are 
common. Pyuria and a positive urine culture are usually present. Gas is 
usually detected by a plain abdominal radiograph or ultrasound . CT is 
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the diagnostic modality of choice, however, because it can localize the 
gas better than ultrasound. Accurate localization of gas is important 
because gas also may form in an infected obstructed collecting system or 
renal abscess; although serious, these conditions do not carry the same 
poor prognosis and are managed differently. 
Renal Malacoplakia 
 Malacoplakia is a chronic granulomatous disorder of unknown 
etiology involving the genitourinary, gastrointestinal, skin, and 
pulmonary systems[21]. It is characterized by an unusual inflammatory 
reaction to a variety of infections and is manifested by the accumulation 
of macrophages containing calcified bacterial debris called Michaelis-
Gutmann bodies . The underlying disorder appears to be a monocyte-
macrophage bactericidal defect. The diagnosis is made by histologic 
examination of involved tissue. Genitourinary malacoplakia, most often 
involving the bladder, is usually associated with gram-negative UTI. 
Patients with renal malacoplakia generally have fever, flank pain, pyuria 
and hematuria, bacteriuria, and, if both kidneys are involved, impaired 
renal function. CT usually shows enlarged kidneys with areas of poor 
enhancement, and the condition may be indistinguishable from other 
infectious or neoplastic lesions. On occasion, the malacoplakia may 
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extend through the renal capsule into the perinephric space, simulating a 
renal carcinoma. 
Picture 8:Renal Malacoplakia 
Xanthogranulomatous Pyelonephritis 
 Xanthogranulomatous pyelonephritis is a poorly understood, 
uncommon but severe chronic destructive granulomatous inflammation of 
renal parenchyma associated with obstruction and infection of the urinary 
tract[22]. The renal parenchyma is replaced with a diffuse or segmental 
cellular infiltrate of foam cells, which are lipid-laden macrophages. The 
process also may extend beyond the renal capsule to the retroperitoneum. 
Its pathogenesis appears to be multifactorial, with infection complicating 
obstruction and leading to ischemia, tissue destruction, and accumulation 
of lipid deposits. Patients with xanthogranulomatous  pyelonephritis are 
characteristically middle-aged women and have chronic symptoms such 
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as flank pain, fever, chills, and malaise. Flank tenderness, a palpable 
mass, and irritative voiding symptoms are common. The urine culture is 
usually positive with E. coli, other gram-negative bacilli, or S. aureus. CT 
generally shows an enlarged nonfunctioning kidney, often the presence of 
calculi and low-density masses (xanthomatous tissue), and in some cases, 
involvement of adjacent structures . It may be difficult to distinguish from 
neoplastic disease. 
Asymptomatic Bacteriuria 
Asymptomatic bacteriuria is common and generally benign. Pyuria 
is often present, especially in elderly people, and is a predictor for 
subsequent symptomatic UTI in some groups. Causative uropathogens 
are the same as those causing UTIs in the same population. Screening for 
and treatment of asymptomatic bacteriuria is generally not warranted. In 
young women with recurrent UTI, asymptomatic bacteriuria may be 
protective against symptomatic recurrence and treatment may increase the 
risk for such recurrences[23].  However, patients at high risk for serious 
complications warrant a more aggressive approach to diagnosis and 
treatment, including pregnant women and patients undergoing urologic 
surgery. Current management strategies in patients with a renal 
transplant, including long-term antimicrobial prophylaxis, help prevent 
both asymptomatic bacteriuria and symptomatic UTI. It is not clear, 
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however, whether screening for or treatment of asymptomatic bacteriuria 
in such patients is worthwhile. Some authorities advise treatment of 
asymptomatic bacteriuria found in patients with anatomic or functional 
abnormalities of the urinary tract, diabetic patients, and patients with 
urea-splitting bacteria (e.g., P. mirabilis, Klebsiella spp.). Evidence based 
guidelines for screening and treatment of asymptomatic bacteriuria in 
these populations are needed.Asymptomatic bacteriuria in catheterized 
patients in hospitals and longterm care facilities, although thought to be 
generally benign, represents a large reservoir of antimicrobial-resistant 
urinary pathogens that increases the risk for cross-infection among 
catheterized patients and results in frequent inappropriate antimicrobial 
use[24]. 
INVESTIGATIONS; 
Urinalysis 
specimen collection 
Specimens must be collected in clean, dry, leak-proof containers.  
Disposable containers should be used because they eliminate the 
chance of contamination owing to improper washing. These disposable 
containers are available in a variety of sizes and shapes, including bags 
with adhesive for the collection of pediatric specimens and large 
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containers for 24-hour specimens. Properly applied screw-top lids are less 
likely to leak than are snap-on lids. Containers for routine urinalysis 
should have a wide mouth to facilitate collections from female patients 
and a wide,flat bottom to prevent overturning. They should be made of a 
clear material to allow for determination of color and clarity. The 
recommended capacity of the container is 50 mL, which allows 12 mL of 
specimen needed for microscopic analysis, additional specimen for repeat 
analysis, and enough room for the specimen to be mixed by swirling the 
container. Individually packaged sterile containers with secure closures 
should be used for microbiologic urine studies. Sterile containers are also 
suggested if more than 2 hours elapse between specimen collection and 
analysis. Specially designed sterile containers are available that have a lid 
with a transfer device that can be assessed with a device called a transfer 
straw. The transfer straw has a needle and an evacuated tube holder. 
Urine can be sterilely transferred to tubes containing preservatives for 
microbiology testing and tubes with conical bottoms for sediment 
analysis or round bottoms for automated reagent strip testing. 
Specimen Preservation 
The most routinely used method of preservation is refrigeration at 
2°C to 8°C, which decreases bacterial growth and metabolism. If the 
urine is to be cultured, it should be refrigerated during transit and kept 
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refrigerated until cultured up to 24 hours. The specimen must return to 
room temperature before chemical testing by reagent strips. When a 
specimen must be transported over a long distance and refrigeration is 
impossible, chemical preservatives may be added. Commercially 
prepared transport tubes are available. The ideal preservative should be 
bactericidal, inhibit urease, and preserve formed elements in the 
sediment. The most routinely used method of preservation is refrigeration 
at 2°C to 8°C, which decreases bacterial growth and metabolism. If the 
urine is to be cultured, it should be refrigerated during transit and kept 
refrigerated until cultured up to 24 hours. The specimen must return to 
room temperature before chemical testing by reagent strips. When a 
specimen must be transported over a long distance and refrigeration is 
impossible, chemical preservatives may be added. Commercially 
prepared transport tubes are available. The ideal preservative should be 
bactericidal, inhibit urease, and preserve formed elements in the 
sediment. 
Midstream Clean-Catch Specimen 
As an alternative to the catheterized specimen, the midstream 
clean-catch specimen provides a safer, less traumatic method for 
obtaining urine for bacterial culture and routine urinalysis. It provides a 
specimen that is less contaminated by epithelial cells and bacteria and, 
31 
 
therefore, is more representative of the actual urine than the routinely 
voided specimen. Patients must be provided with appropriate cleansing 
materials, a sterile container, and instructions for cleansing and voiding. 
Strong bacterial agents, such as hexachlorophene or povidone-iodine, 
should not be used as cleansing agents. Mild antiseptic towelettes are 
recommended. Some urine collection transfer kits contain Castile Soap 
Towelettes. 
Suprapubic Aspiration 
Occasionally urine may be collected by external introduction of a 
needle through the abdomen into the bladder. Because the bladder is 
sterile under normal conditions, suprapubic aspiration provides a sample 
for bacterial culture that is completely free of extraneous contamination. 
The specimen can also be used for cytologic examination. 
Bacteria 
Bacteria are not normally present in urine. However, unless 
specimens are collected under sterile conditions (catheterization), a few 
bacteria are usually present as a result of vaginal, urethral, external 
genitalia, or collection-container contamination. These contaminant 
bacteria multiply rapidly in specimens that remain at room temperature 
for extended periods, but are of no clinical significance. They may 
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produce a positive nitrite test result and also frequently result in a pH 
above 8, indicating an unacceptable specimen. Bacteria may be present in 
the form of cocci (spherical) or bacilli (rods). Owing to their small size, 
they must be observed and reported using high-power magnification. 
They are reported as few, moderate, or many per high-power field.To be 
considered significant for UTI, bacteria should be accompanied by 
WBCs. Some laboratories report bacteria only when observed in fresh 
specimens in conjunction with WBCs . The presence of motile organisms 
in a drop of fresh urine collected under sterile conditions correlates well 
with a positive urine culture. Observing bacteria for motility also is useful 
in differentiating them from similarly appearing amorphous phosphates 
and urates. The use of phase microscopy aids in the visualization of 
bacteria. 
Microscopic Examination 
Much can be learned from simple microscopic examination of 
urine. A drop of fresh uncentrifuged urine placed on a slide, covered with 
a coverglass, and examined with restricted light intensity under the high-
dry objective of an ordinary clinical microscope can reveal leukocytes, 
epithelial cells, and bacteria if more than 105/mL are present. Finding 105 
organisms per milliliter in a properly collected and examined urine 
specimen is strong evidence of active urinary tract infection. A Gram 
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stained smear of uncentrifuged midstream urine that shows gram-negative 
rods is diagnostic of a urinary tract infection. 
Brief centrifugation of urine readily sediments pus cells, which 
may carry along bacteria and thus may help in microscopic diagnosis of 
infection. The presence of other formed elements in the sediments—or 
the presence of proteinuria—is of little direct aid in the specific 
identification of active urinary tract infection. Pus cells may be present 
without bacteria, and, conversely, bacteriuria may be present without 
pyuria. The presence of many squamous epithelial cells, lactobacilli, or 
mixed flora on culture suggests improper urine collection. Some urine 
dipsticks contain leukocyte esterase and nitrite, measurements of 
polymorphonuclear cells and bacteria, respectively, in the urine. Positive 
reactions are strongly suggestive of bacterial urinary tract infection. 
Although not readily embraced by clinical microbiology laboratories, 
many chemistry laboratories have implemented automated or 
semiautomated instruments for routine performance of urinalysis. A 
variety of techniques are used by these instruments to detect leukocytes 
and bacteria. The performance of these systems varies, but they bring a 
level of standardization for high-volume testing that may not be 
accomplished using dipstick methods. 
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Culture 
Culture of the urine, to be meaningful, must be performed 
quantitatively. Properly collected urine is cultured in measured amounts 
on solid media, and the colonies that appear after incubation are counted 
to indicate the number of bacteria per milliliter. The usual procedure is to 
spread 0.001–0.05 mL of undiluted urine on blood agar plates and other 
solid media for quantitative culture. All media are incubated overnight at 
37°C; growth density is then compared with photographs of different 
densities of growth for similar bacteria, yielding semiquantitative data. In 
active pyelonephritis, the number of bacteria in urine collected by ureteral 
catheter is relatively low. While accumulating in the bladder, bacteria 
multiply rapidly and soon reach numbers in excess of 105/mL—far more 
than could occur as a result of contamination by urethral or skin 
microbiota or from the air. Therefore, it is generally agreed that if more 
than 105 colonies/mL are cultivated from a properly collected and 
properly cultured urine specimen, this constitutes strong evidence of 
active urinary tract infection. The presence 105 bacteria or more of the 
same type per milliliter in two consecutive specimens establishes a 
diagnosis of active infection. 
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ULTRASOUND 
The infection may be either acute or chronic. Ultrasound signs of 
renal infection may be absent altogether, and this is the commonest 
scenario as the infective episode has often been successfully treated with 
antibiotics by the time the ultrasound scan is performed. The infection 
may be confined to the bladder, that is cystitis, in which case low-level 
echoes and/or hyperechoic debris may be identified, or may have 
progressed to the kidneys. Scarring and/or cortical thinning may be 
present in cases of repeated infections. 
Pyelonephritis 
Acute pyelonephritis 
Acute inflammation of the kidney rarely results in any ultrasound 
abnormality. Occasionally the kidney may be enlarged and hypoechoic, 
the contrast between the kidney and the hepatic or splenic parenchyma 
increasing due to oedema, but the ultrasound changes are generally 
subtle. The normally clear differentiation between the cortex and the 
medullary pyramids may become indistinct, but again may go 
unrecognized. CT is useful for detecting subtle inflammatory changes 
within the kidney. 
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Figure 9. 
Chronic pyelonephritis 
This chronic inflammatory state is usually the result of frequent 
previous inflammatory/infective episodes. The kidney may be small and 
often has focal scarring present. Scar tissue has the appearance of a 
hyperechoic, linear lesion which affects the smooth renal outline and 
crosses the renal cortex . (Do not confuse focal scarring with fetal 
lobulation: the latter is smooth, thin, continuous with the capsule and 
forms an indentation between the pyramids.) The renal cortex is 
frequently thin in chronic pyelonephritis and may appear abnormally 
hyperechoic. 
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Figure 10. 
Bladder diverticula  
Repeated infections can cause the bladder wall to thicken and 
become trabeculated. In such cases, a bladder diverticulum may form, 
making treatment of subsequent infections particularly difficult. The 
diverticulum may harbour debris or stones and may fail to empty 
properly, often enlarging as the urine refluxes into it when the patient 
micturates . 
Focal pyelonephritis 
The presence of acute infection within the kidney may progress in 
focal regions of the renal parenchyma. This phenomenon is particularly 
associated with diabetics. The ultrasonic changes are subtle, as in diffuse 
pyelonephritis, but it is possible to detect a slight change in echogenicity 
when it is surrounded by normal-looking parenchyma. Focal 
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pyelonephritis (sometimes called focal nephronia) may be either hypo- or 
hyperechoic compared with normal renal tissue. Depending on the size of 
the lesion, it may cause a mass effect, mimicking a renal tumour. The 
outline of the kidney is preserved, however the patient presents with fever 
and tenderness on the affected side and frequently has a history of urinary 
tract infection. A focal renal mass under these circumstances is highly 
suggestive of focal pyelonephritis and is also well demonstrated on 
CT[25].  It usually responds to antibiotic therapy and resolution of the 
lesion can be monitored with ultrasound scans. Focal pyelonephritis can 
progress to form an abscess in the kidney, which can normally be treated 
by percutaneous drainage and antibiotics. 
Renal abscess 
A renal abscess is generally a progression of focal inflammation 
within the kidney. The area liquefies and may enlarge to form a complex 
mass with distal acoustic enhancement. Low-level echoes from pus may 
fill the abscess cavity, giving it the appearance of increased echogenicity, 
but it may also be hypoechoic. The margins of the abscess may be ill-
defined at first but may develop a more obvious capsule as the lesion 
becomes established , this capsule often has an easily identifiable thick 
rim. Flow may be seen in the inflammatory capsule with colour Doppler, 
but not in the liquefied centre. A renal abscess may mimic a lymphoma as 
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both may be hypoechoic on ultrasound, and both may have either single 
or multiple foci. The abscess may be intrarenal, subcapsular or perirenal. 
Frequently, drainage under ultrasound guidance is the preferred 
treatment; gradual resolution of the abscess can also be monitored with 
ultrasound. 
Picture 11:CT image of Renal abscess 
Tuberculosis (TB) 
Renal TB is an uncommon finding and a difficult diagnosis to 
make on ultrasound. The subtle inflammatory changes which affect the 
calyces in the early stages are best demonstrated with CT. In the later 
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stages ultrasound may show calcific foci and obstructed calyces as a 
result of thickened inflammatory calyceal walls, calcification and debris. 
TB frequently spreads to other adjacent sites in  the abdomen, including 
the psoas muscle and gastrointestinal tract. The differential diagnosis is 
xanthogranulomatous pyelonephritis, which is often indistinguishable 
from TB on ultrasound, or a necrotic renal neoplasm. 
 
Figure 12. 
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Xanthogranulomatous pyelonephritis (XGP) 
This condition (which gets its name from the yellow colour of the 
kidney) is the result of renal obstruction by calculi in the pelvicalyceal 
system. Frequently, a staghorn calculus is responsible. The kidney 
becomes chronically infected and the calyces enlarge and become filled 
with infected debris. The cortex may be eroded and thin. On ultrasound, 
these appearances are similar to TB or to a pyonephrosis. The latter is 
usually accompanied by a more severe, acute pain and fever whereas 
XGP or TB has a lower-grade, chronic pain. CT may differentiate TB 
from XGP and is also more sensitive to extrarenal spread of disease. 
CT SCAN 
Acute pyelonephritis 
CT is the modality of choice for evaluating the parenchymal 
involvement of acute pyelonephritis, sometimes referred to as acute 
bacterial nephritis. It provides comprehensive anatomic and physiologic 
information that accurately characterizes both intrarenal and extrarenal 
pathologic conditions. Unenhanced CT is excellent for identifying urinary 
tract gas, calculi, hemorrhage, renal enlargement, inflammatory masses, 
and obstruction[26].  However, unenhanced CTimages may appear normal. 
On postcontrast studies, acute bacterial nephritis most commonly 
42 
 
manifests as one or more wedge-shaped areas or streaky zones of lesser 
enhancement that extend from the papilla to the renal cortex in the 
nephrographic phase, also known as striated nephrogram. In the delayed 
phase, reversal of the striated nephrogram occurs. Other findings include 
enlargement of the affected kidney due to edema, perinephric stranding, 
and areas of increased attenuation if hemorrhagic bacterial nephritis is 
present and thickening of the renal pelvis and ureteric wall. In progressive 
cases, a parenchymal abscess may develop. On CT, before liquefaction 
becomes evident, the abscess may resemble a renal mass, especially in 
the absence of typical clinical findings. Abscesses typically appear as 
round or geographic low-attenuation collections that do not enhance 
centrally but may have an enhancing rim .  The rims are pseudocapsules 
with varied wall thicknesses and frequent nodularity. A halo of 
diminished enhancement may surround the abscess during the 
nephrographic phase. Extraparenchymal collections occasionally extend 
into adjacent structures, such as the psoas muscle. Persistent urinary 
leukocytes indicate residual inflammation that can usually be detected on 
CT[27,28]. 
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Picture 13:CT image of Acute Pyelonephritis 
Chronic pyelonephritis 
Imaging findings include renal scarring, atrophy, and cortical 
thinning; hypertrophy of residual normal tissue (which may mimic a mass 
lesion); calyceal clubbing secondary to retraction of the papilla from the 
overlying scar; dilatation of the calyceal system; and overall renal 
asymmetry. 
Emphysematous Pyelonephritis 
Two types of gas distribution have been reported. Type 1 (33 % of 
cases) is more aggressive and is characterized by renal parenchymal 
destruction that manifests with streaky or mottled areas of gas without 
intrarenal or extrarenal fluid collections . Type 2 (66 %) is less aggressive 
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andis characterized by renal or perirenal fluid collections associated with 
bubbly or loculated gas or by gas in the urinary collecting system. 
Xanthogranulomatous Pyelonephritis 
Diffuse (>80 %) or segmental imaging findings may be present. In 
the segmental form, the process may have the appearance of a renal mass 
and may be indistinguishable from RCC. In the more common diffuse 
form, the kidney is enlarged, with poor or no function. When extension 
occurs outside the kidney, it may involve the psoas muscle, and there may 
be fistulas to the abdominal wall. Most cases occur in association with a 
renal pelvic calculus; thus, hydronephrosis is thought to be a contributing 
factor[29]. CT is the imaging modality of choice for diagnosis and 
management. Findings include an enlarged kidney, with decreased or 
absent function; peripheral cystic dilatation; enhancing walls of the 
abscess cavities; perinephric extension; and a large central calculus. 
Stones are often laminated or branching in appearance. 
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C Reactive Protein 
CRP and many other APR can influence multiple stages of 
inflammation, and CRP has both pro inflammatory and anti inflammatory 
actions, although the primary effect may be anti inflammatory[30,31] . CRP 
can promote the recognition and elimination of pathogens and enhance 
the clearance of necrotic and apoptotic cells[32-38]. The protein consists of 
five identical, non-covalently associated subunits, each with a molecular 
weight of approximately 23 kD, which are arranged symmetrically 
around a central pore[39] . CRP and related proteins with this structure are 
termed pentraxins, which are a family of pattern recognition molecules 
involved in the innate immune response; others include serum amyloid P 
and a number of pattern recognition molecules referred to as long 
Picture 15:CT image of XGPN 
46 
 
pentraxins. A major function of CRP is its ability to bind phosphocholine, 
thereby permitting recognition both of foreign pathogens that display this 
moiety and phospholipid constituents of damaged cells . CRP can also 
activate the complement system and bind to phagocytic cells via Fc 
receptors, suggesting that it can initiate elimination of pathogens and 
targeted cells by interaction with both humoral and cellular effector 
systems of inflammation. These functions of CRP may have negative 
effects in some settings. As an example, CRP levels are increased in 
patients with immune thrombocytopenia (ITP), where CRP may amplify 
antibody-mediated platelet destruction upon binding to phosphocholine 
that is exposed after oxidation triggered by anti platelet antibodies. Pro 
inflammatory effects of CRP include activation of the complement 
system and the induction in  monocytes of inflammatory cytokines and 
tissue factor  and shedding of the IL-6 receptor . As a result, the CRP 
response to tissue injury may worsen tissue damage in some settings . 
 C-reactive protein — Elevations of CRP occur in association 
with acute and chronic inflammation due to a range of causes, including 
infectious diseases and non infectious inflammatory disorders. Very small 
changes in CRP levels, detected with highly-sensitive assays, may also 
occur in association with metabolic stresses in the absence of acute or 
chronic inflammatory states as they have traditionally been viewed. 
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'Normal' CRP levels  
The level of CRP that is truly normal or clinically innocuous is not 
known. Data from a study conducted by the National Health and 
Nutrition Evaluation Survey of over 21,000 people in the United States 
revealed that CRP levels vary with age, sex, and race, with slightly higher 
levels seen with increased age, with female sex, and in African 
Americans . A rough correction of the CRP for age can be made by using 
the following formulas: the upper limit of the reference range (mg/dL) 
equals (age in years)/50 for men and (age in years/50) + 0.6 for 
women[40,41] . It is very important to note that there is no uniformity in the 
units that are used to report CRP levels. Some laboratories report CRP 
concentrations as mg/dL while others employ mg/L. Standard CRP 
determinations may be reported either in units of mg/dL or in units of 
mg/L, while determinations using a highly sensitive assay, generally 
referred to as "high-sensitivity CRP" (hs-CRP), are routinely reported in 
units of mg/L. Population studies reveal a skewed, rather than Gaussian, 
distribution of plasma CRP concentrations. About 70 to 90 percent of 
samples from reference populations have CRP concentrations under 0.3 
mg/dL (3 mg/L), but some individuals have minor elevations up to 1 
mg/dL (10 mg/L). What we commonly call normal ranges (properly 
called reference ranges) for CRP vary greatly from one laboratory to 
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another, to a degree that cannot be explained on a biologic or technical 
basis. What is thus regarded as "elevated" is often misleading. It would be 
best to regard CRP concentrations >1 mg/dL (10 mg/L) as indicating 
clinically significant inflammation while concentrations between 0.3 and 
1 mg/dL (3 and 10 mg/L) indicate what is commonly referred to as low-
grade inflammation. Low-grade inflammation is not accompanied by the 
classic signs of inflammation and may result from an immense number of 
metabolic stresses . Some of these stresses are clinically apparent; 
examples include atherosclerosis, obesity, obstructive sleep apnoea, 
insulin resistance, hypertension, and type 2 diabetes. Low grade 
inflammation is, however, also associated with an astounding number of 
conditions and lifestyles known to be associated with poor health, 
including low levels of physical activity, prehypertension , a large variety 
of unhealthy diets, social isolation, and even being unmarried . 
Moderate to marked elevation of CRP — In most inflammatory 
conditions, the CRP, like the ESR, becomes elevated as part of the acute 
phase response. Markedly elevated levels of CRP are strongly associated 
with infection. Infections, most often bacterial, were found in 
approximately 80 percent of patients with values in excess of 10 mg/dL 
(100 mg/L) and in 88 to 94 percent of patients with values over 50 mg/dL 
(500 mg/L). Levels of CRP may also be elevated in patients with viral 
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infections, although usually not to the degree seen in patients with 
bacterial infection .ESR and CRP levels may be discrepant due to 
differences in kinetics, with the CRP both rising and decreasing more 
rapidly; or related to characteristics of the inflammatory or and immune-
disease related mechanisms, as in systemic lupus, where significant CRP 
elevations are typically not as common or to as great a degree as are 
increases in the ESR.  
High-sensitivity CRP and low-grade inflammation; 
Some confusion has arisen because of widespread use of the terms 
"high-sensitivity CRP" and "low-grade inflammation" . One common 
misunderstanding has been the incorrect belief that hs-CRP is different in 
some way from the CRP that has been measured for many years. It is not. 
"High-sensitivity" only means that the concentration of CRP was 
determined using an assay designed to measure and distinguish very low 
levels of CRP. The CRP that is measured has no new or unique properties 
. Minor CRP elevation (concentrations between 3 and 10 mg/L) has been 
generally regarded as a marker of what has been called low-grade 
inflammation. However, this poorly defined state, sometimes referred to 
as mini inflammation or subclinical inflammation, occurs in many 
conditions in which there are minor degrees of metabolic dysfunction, 
such as obesity and insulin resistance, unlike inflammation as it has 
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traditionally been understood. Moreover, the low-grade inflammatory 
state differs in several important ways from the acute inflammation that 
occurs in response to infection or tissue injury[42,43]. The acute 
inflammatory state is associated with the classic signs of inflammation 
(swelling,  erythema, warmth, and pain), while low-grade inflammation is 
not. Acute inflammation generally shows a marked CRP response while 
low-grade inflammation shows only minor CRP elevation. The 
inflammatory response to infection and tissue injury supports host 
defense,  clearance of necrotic tissue, adaptation, and repair, while the 
purpose of low grade inflammation appears to be restoration of metabolic 
homeostasis. The factors that trigger the acute inflammatory response and 
low-grade inflammation differ as well. Acute inflammation is largely 
triggered by  components of an invading pathogen, referred to as 
pathogen-associated molecular patterns (PAMPs), and by products of 
damaged cells, damage- (or danger-) associated molecular patterns 
(DAMPs). The latter are sometimes referred to as  alarmins . One 
molecular mechanism that can trigger low-grade inflammation and CRP 
induction in response to metabolic stress that has been well-studied is the 
unfolded protein response . These differences between acute 
inflammation and low-grade inflammation are so great that two leading 
researchers in the field have suggested distinct nomenclatures for the 
latter; both "para-inflammation" and "metaflammation" (metabolically-
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triggered inflammation) have been proposed to emphasize the distinction 
between metabolic perturbation and inflammation as it is traditionally 
viewed, both of which may result in increases in CRP levels. 
Figure 17. 
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TREATMENT OF UTI; 
Picture 18:Oral medications for UTI 
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Picture 19:Parenteral Management of UTI 
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Picture 20 
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Picture 21 
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Picture 22 
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Picture 23 
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Picture 24 
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MATERIALS AND METHODS 
Study center; 
Institute of Internal Medicine Madras Medical College and Rajiv 
Gandhi Government General Hospital. Chennai-03. 
Study Design; 
Single  center Observational Study 
Sample size; 
100 patients with urinary tract infection attending Internal 
Medicine OPD or admitted in wards based on inclusion & exclusion 
criteria. The required sample size was calculated based on the formula 4* 
(prevalence of disease)* 
 (1- prevalence of disease) / Error range. 
Collaborating Departments; 
Institute of Microbiology, MMC & RGGGH,CH-3. 
Institute of Radiology ,MMC & RGGGH,CH-3. 
Institute of Biochemistry ,MMC & RGGGH,CH-3. 
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Study Duration; 
¾ 1 year 
Study plan; 
 Based on previous  studies, the  mean value of C-reactive 
protein in upper urinary tract infection was 116.9 mg/L and lower urinary 
tract infection was 14.5 mg/L[44]. About 100 patients attending general 
medicine OPD and admitted in general medicine wards were subjected to 
detailed history taking, clinical examination and investigations such as 
CBC, Urine culture & Sensitivity, Serum CRP levels, USG KUB,CT-
KUB(whenever necessary). 
Inclusion criteria; 
Patients with urine samples showing positive urine culture and 
patients showing symptoms of UTI. 
Exclusion criteria; 
Patients with inflammatory conditions other than UTI, history of 
trauma, pregnancy, USG proven renal calculi. 
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Serum CRP Assay Method: 
C-reactive protein (CRP) levels in human serum based on the 
catalytic activity of gold nanoparticles  and luminol-H2O2 
chemiluminescence. The Chemiluminescence intensity in the presence of 
CRP and its ligand, O phosphorylethanolamine, was greatly enhanced 
due to the aggregation of Gold Nano Particles after the addition of 0.5M 
NaCl. 
Statistical Analysis Plan: 
Data analysed using statistical package - SPSS Software 
Consent 
All participants / attenders  gave written informed consent. 
Ethical Committee Approval 
Institutional Ethics Committee of Madras Medical College approved 
the study. 
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RESULTS 
 Among 100 patients with UTI, 13% of patients belong to the age 
group of 20-40 years, 41% between 41-60 years, 42% between 61-80 
years and 4% of them was above 80 years. The proportion of subjects in 
each group among various age range are given in table-1 and figure-25. 
Age group Frequency Percent 
20-40 years 13 13.0 
41-60 years 41 41.0 
61-80 years 42 42.0 
above 80 years 4 4.0 
Total 100 100.0 
Table 1:Age distibution of patients with UTI 
 
Picture 25:Age distribution of subjects 
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Among 100 cases ,26 were males and 74 were females. 
Table 2: Sex wise distribution of cases 
SEX Frequency Percent 
Male 26 26.0 
Female 74 74.0 
Total 100 100.0 
 
 
Figure 26:Gender Distribution of patients 
 
  The most common accompanying illness in patients include DM 
only comprising of about 38%,plus BPH and Cerebrovascular Accident 
each occupying 2%. 
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Location of UTI Frequency Percent 
lower 55 55.0 
Upper 45 45.0 
Total 100 100.0 
Table 4. 
  
 
Figure 28. 
 
The most common symptoms in patient with lower urinary tract 
infection include Dysuria(85%), lower abdominal pain(25%), 
urgency(16%), frequency(13%). 
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Figure 29. 
 
  % 
Dysuria 46 84% 
urgency 9 16% 
frequency 7 13% 
lower abdominal pain 14 25% 
Table 4. 
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 The symptoms in patients with infection involving upper urinary 
tract include Fever (96%),chills(38%),vomiting (36%),loin pain(18%), 
Diabetic ketoacidosis (13%).  
 
Figure 30 
Fever 43 96% 
Loin pain 8 18% 
Urgency,Frequency 1 2% 
Chills 17 38% 
Vomiting 16 36% 
Nausea 1 2% 
DKA 6 13% 
Rigor 4 9% 
 
Table 5. 
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 The bacterial organisms in UTI was of gram negative bacilli of 
which E.coli was most common present in about 73%. 
  
URINE CULTURE Frequency Percent 
Acinetobacter 1 1.0 
E.coli 73 73.0 
klebsiella 4 4.0 
Normal 16 16.0 
Proteus 2 2.0 
Pseudomonas 4 4.0 
Total 100 100.0 
Table 6. 
 
Figure 31. 
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 Ultrasound abdomen & pelvis was done in all patients with 
symptoms of urinary tract infection which showed cystitis in 30 out of 55 
patients with lower urinary tract infection.Other significant findings 
include prostatomegaly, pyelonephritis, Hydroureteronephrosis. 
USG KUB Frequency Percent 
Grade 1 
prostatomegaly 
5 5.0 
Grade 2 
prostatomegaly 
2 2.0 
Lt.pyelonephritis 2 2.0 
Normal 43 43.0 
Cystitis 30 30 
Rt.HUN 6 6.0 
Rt.pyelonephritis 12 12.0 
Total 100 100.0 
Table 7. 
70 
 
 
Figure 32. 
  Non contrast CT-KUB was done in all patients with 
symptoms of upper urinary tract infection which showed better diagnostic 
value compared to ultrasound abdomen. 
CT KUB(IF DONE) Frequency Percent 
B/L Pyelonephritis 4 8.5% 
Lt.pyelonephritis 15 31.9% 
Lt.pyelonephritis with 
HUN 1 2.1% 
Normal 2 4.3% 
Rt.HUN 1 2.1% 
Rt.pyelonephritis 18 38.3% 
Rt.pyelonephritis with 
HUN 6 12.8% 
Total 47 100.0% 
Table 8. 
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Figure 33. 
 
 The mean value of CRP in subjects with upper UTI(159.20) was 
significantly higher than the mean value of lower UTI(16.16).  
 
Group Statistics 
 
 
Location 
of UTI 
N Mean Std. 
Deviation
Std. 
Error 
Mean 
Z test 
CRP 
LEVELmgL
lower 55 16.1564 10.40704 1.40329 8.574**
Upper 45 159.2089 49.12149 7.32260  
**p<0.001 
Table 9. 
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Figure 34. 
 Statistic 
CRP LEVELmgL 
Mean 80.5300 
95% Confidence 
Interval for Mean 
Lower Bound 64.8465 
Upper Bound 96.2135 
Median 31.9000 
Variance 6247.492 
Std. Deviation 79.04108 
Minimum 1.50 
Maximum 249.50 
Table 10. 
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 Location of UTI Statistic 
CRP LEVELmgL 
lower 
Mean 16.1564 
95% Confidence 
Interval for Mean 
Lower Bound 13.3429 
Upper Bound 18.9698 
5% Trimmed Mean 16.0212 
Median 14.2000 
Variance 108.307 
Std. Deviation 10.40704 
Minimum 1.50 
Maximum 33.50 
Upper 
Mean 155.8756 
95% Confidence 
Interval for Mean 
Lower Bound 139.5811 
Upper Bound 172.1701 
5% Trimmed Mean 157.0210 
Median 166.8000 
Variance 2941.618 
Std. Deviation 54.23668 
Minimum 5.00 
Maximum 249.50 
. 
 Table 11
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 CRP level 123 Total 
<31.9 
Median 
>31.9 
Median 
age 
group 
20-40 years 
Count 6 7 13 
%  12.0% 14.0% 13.0%
41-60 years 
Count 20 21 41 
%  40.0% 42.0% 41.0%
60-80 years 
Count 20 22 42 
%  40.0% 44.0% 42.0%
above 80 
years 
Count 4 0 4 
%  8.0% 0.0% 4.0% 
Total 
Count 50 50 100 
%  100.0% 100.0% 100.0%
Pearson Chi-Square=4.197 p=0.241 
Table 12. 
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 CRP level 123 Total 
<31.9 
Median 
>31.9 
Median 
Comorbidities 
BPH 
Count 2 2 4 
%  4.0% 4.0% 4.0% 
CVA 
Count 3 1 4 
%  6.0% 2.0% 4.0% 
DM 
Count 10 28 38 
%  20.0% 56.0% 38.0%
DM,BPH
Count 0 2 2 
%  0.0% 4.0% 2.0% 
DM,CVA
Count 0 2 2 
%  0.0% 4.0% 2.0% 
DM,SHT
Count 1 0 1 
%  2.0% 0.0% 1.0% 
N 
Count 34 15 49 
%  68.0% 30.0% 49.0%
Total 
Count 50 50 100 
%  100.0% 100.0% 100.0%
Pearson Chi-Square=21.894**  p<0.001 
Table 14. 
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 CRP level 123 Total 
<31.9 
Median 
>31.9 
Median 
URINE 
CULTURE  
Acinetobacter
Count 0 1 1 
%  0.0% 2.0% 1.0% 
E.coli 
Count 35 38 73 
%  70.0% 76.0% 73.0%
klebsiella 
Count 0 4 4 
%  0.0% 8.0% 4.0% 
N 
Count 15 1 16 
%  30.0% 2.0% 16.0%
Proteus 
Count 0 2 2 
%  0.0% 4.0% 2.0% 
Pseudomonas
Count 0 4 4 
%  0.0% 8.0% 4.0% 
Total 
Count 50 50 100 
%  100.0% 100.0% 100.0%
Pearson Chi-Square=23.373 **  p<.001 
Table 15. 
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 CRP level 123 Total 
<31.9 
Median 
>31.9 
Median 
USG 
KUB 
Grade 1 
prostatomegaly 
Count 3 2 5 
%  6.0% 4.0% 5.0% 
Grade 2 
prostatomegaly 
Count 2 0 2 
%  4.0% 0.0% 2.0% 
Lt.pyelonephritis
Count 0 2 2 
%  0.0% 4.0% 2.0% 
Normal study 
Count 45 28 73 
%  90.0% 56.0% 73.0%
Rt.HUN 
Count 0 6 6 
%  0.0% 12.0% 6.0% 
Rt.pyelonephritis
Count 0 12 12 
%  0.0% 24.0% 12.0%
Total 
Count 50 50 100 
%  100.0% 100.0% 100.0%
Pearson Chi-Square=26.159 ** p<.001 
Table 16. 
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 CRP level 123 Total 
<31.9 
Median 
>31.9 
Median 
CT 
KUB(IF 
DONE) 
 
Count 48 5 53 
%  96.0% 10.0% 53.0%
B/L 
Pyelonephritis 
Count 0 4 4 
%  0.0% 8.0% 4.0% 
Lt.pyelonephritis
Count 0 15 15 
%  0.0% 30.0% 15.0%
Lt.pyelonephritis 
with HUN 
Count 0 1 1 
%  0.0% 2.0% 1.0% 
Normal 
Count 2 0 2 
%  4.0% 0.0% 2.0% 
Rt.HUN 
Count 0 1 1 
%  0.0% 2.0% 1.0% 
Rt.pyelonephritis
Count 0 18 18 
%  0.0% 36.0% 18.0%
Rt.pyelonephritis 
with HUN 
Count 0 6 6 
%  0.0% 12.0% 6.0% 
Total 
Count 50 50 100 
%  100.0% 100.0% 100.0%
Pearson Chi-Square=26.159** p<.0014 
Table 17. 
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DISCUSSION 
 In UTI differentiation between upper and lower urinary tract 
infection has prognostic significance. The distinction between lower and 
upper tract infection is more important because renal involvement can 
induce parenchymal scarring that may lead to arterial hypertension and 
chronic renal failure. 
 The present study was undertaken to determine the levels of 
CRP in patients with the diagnosis of urinary tract infection and to 
compare the levels of CRP in relationship to upper and lower UTI. In the 
present study UTI was commonly seen in the age group between 40-80 
years(83%) and predominantly involved female patients(74%).UTI was 
less commonly seen in young  patients. In the age group of 20-40 years, 
only 13%  had UTI. A similar result was observed by ML Pursnani et al. 
in which 65.52% cases were females and rest  34.48% cases were males. 
 Diabetes mellitus which have been considered as an 
important risk factor for UTI were evaluated in the present study. 
Majority of patients in this study have DM accounting for 38%% and 
49% of cases presents with no comorbidities. In India, large number of 
populations is found be diabetics accounting for 32 million at present and 
is expected to rise to 57.2 million by 2025. Neutrophil chemotaxis and 
adherence to vascular endothelium, phagocytosis, intracellular 
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bactericidal activity, opsonization, and cell-mediated immunity are all 
depressed in diabetics with hyperglycemia predisposing them to increased 
susceptibility to infections. Other  comorbid illness associated with 
urinary tract infection include  prostatitic enlargement, cerebrovascular 
accident. 
The results in present study showed that mean CRP level was 
found to be higher among patients with upper urinary tract infection 
(159.21mg/L) compared to lower urinary tract infection(16.16 mg/L).  
 Bharath MS et al. have studied the levels of CRP  levels in patients 
with urinary tract infection and in their study the mean value of C-
reactive protein in upper urinary tract infection was 116.9 mg/L and 
lower urinary tract infection was 14.5 mg/L . This shows that C-reactive 
protein is significantly raised in upper urinary tract infection.  means that 
C-reactive protein can be used to diagnose inflammation in upper urinary 
tract infection. This confirms the observation of Gervaix, Alain MD et al, 
Stanley Haller stein et al (1982), Jodal and Hanson (1976), who studied 
the usefulness of sequential determination of C-reactive protein value in 
acute  pyelonephritis. A study of  Chieh-Wei Yen et al showed that longer 
febrile period and high C-reactive protein level are good indicators of 
prediction of the risk of pyelonephritis in urinary tract infection patients. 
Fever or an elevated C-reactive protein level often accompanies acute 
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pyelonephritis and is found in rare cases of cystitis but also occurs in 
infections other than pyelonephritis. Till date only a few studies are 
available in adult age group. 
Xu et al. have found that the serum CRP levels of the Acute 
Pyelonephritis group were significantly higher than those of the lower 
UTI group (68.17 ± 39.42 mg/l vs. 21.39 ± 14.92 mg/l, P < 0.01, ). 
Correlation analysis demonstrated that CRP were in a significantly 
positive correlation with a correlation coefficient of 0.729 (P < 0.01). 
The organisms which were isolated in patients with urinary tract 
infection include E.coli(73%), klebsiella(4%) ,pseudomonas(4%), 
proteus(2%), acinetobacter(1%) and culture was normal in 16% of the 
patients  who was previously treated with antibiotics. Moreover longer 
follow up studies with persistence of same degree of elevation of C-
reactive protein may point to high risk cases which are likely to develop 
chronic parenchymal renal disease with hypertension in future. 
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CONCLUSION 
¾ In the present study, serum CRP levels were found to be 
significantly higher in patients with upper urinary tract infection 
compared to lower urinary tract infection. 
¾ Serum C-Reactive  Protein level measurements can be done in 
patients with symptoms of urinary tract infection especially in 
individuals with risk factors such as Diabetes Mellitus to make an 
prediction of upper urinary tract involvement. 
¾ Early initiation of empirical antibiotic therapy can be done as for 
Complicated UTI in patients with higher CRP levels to prevent 
renal scarring. 
¾ CRP  levels can also  be used for observing pathogenesis and 
curative effect ,which is a non-invasive test and is not associated 
with morbidity and also economically feasible in tertiary and 
peripheral setting. 
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LIMITATIONS 
¾ Sample size of the study is very small, hence further studies large 
number of cases is required. 
¾ The study was conducted in patients admitted at a single tertiary 
care center.  
¾ This was a cross sectional case control study and follow up details 
were not evaluated. 
¾ Majority of the patients with UTI were females occupying nearly 
75%. 
¾ It was also very difficult to exclude other inflammatory conditions 
that can cause rise in C-Reactive Protein levels. 
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A STUDY OF ROLE OR BLOOD CRP LEVELS IN UPPER 
AND LOWER URINARY TRACT INFECTIONS 
Name : 
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Address : 
Contact No. : 
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◊ Fever 
◊ Loin pain 
◊ Dysuria 
◊ Frequency 
◊ Urgency 
PATIENT CHARACTERISTICS 
◊ Age 
◊ sex 
◊ pregnancy status 
EXAMINATION 
◊  Temperature 
◊ Loin tenderness 
URINE CULTURE &SENSITIVITY 
CRP LEVEL; 
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DIFFERENTIATE UPPER AND LOWER TRACT INFECTIONS 
WITH BLOOD CRP LEVELS” among patients attending Rajiv  
Gandhi Government General Hospital, Chennai and for that your 
specimen may be valuable to us. 
The purpose of this study is to explore a diagnostic method to 
differentiate for upper and lower urinary tract infection .We are selecting 
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management. 
The privacy of the patients in the research will be maintained 
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withdraw from the study I agree to this access. However, I 
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unexpected or unusual symptoms. 
I hereby consent to participate in this study. 
I hereby give permission to undergo complete clinical 
examination and diagnostic tests including hematological, 
biochemical, radiological tests. 
 
Signature/thumb impression   Signature of Investigator 
Patient’s Name and Address           Dr.R.KRISHNA 
  
ETHICAL COMMITTEE APPROVAL FORM 
 
 
PLAGIARISM REPORT 
 
  
PLAGIARISM CERTIFICATE 
This is to certify that this dissertation work titled “A STUDY 
TO DIFFERENTIATE UPPER AND LOWER URINARY 
TRACT INFECTIONS WITH BLOOD CRP LEVELS” of the 
candidate Dr.R.KRISHNA with registration Number 201611011 
for the award of M.D. in the branch of GENERAL MEDICINE. I 
personally verified the urkund.com website for plagiarism Check. I 
found that the uploaded thesis file contains from introduction to 
conclusion pages and result shows 2 percentage of plagiarism in the 
dissertation. 
 
 
 
    Guide & Supervisor sign with Seal. 
 
